COVID vaccine reduces severity of illness, death for adults, especially among at-risk populations
A new multi-state study led by the Centers for Disease Control and Prevention’s (CDC) VISION Network – including Regenstrief Institute – has provided the most comprehensive assessment to date of the effectiveness of 2023-2024 COVID-19 vaccines among adults in the U.S. during the XBB and JN.1 Omicron subvariant waves.
Data suggest that receiving updated COVID-19 vaccines remains crucial, especially for older adults and those at increased risk for severe outcomes, and underscores the additional protection provided ...